高级检索+

m6A阅读蛋白IGF2BP1对食管鳞状细胞癌细胞生物学行为的影响及其机制探讨

The Effect of the m~6A Reader Protein IGF2BP1 on the Biological Behavior of Esophageal Squamous Cell Carcinoma Cells and Mechanism Exploration

  • 摘要: 本研究旨在探讨胰岛素样生长因子-2 mRNA结合蛋白1(insulin like growth factor 2 mRNA binding protein 1, IGF2BP1)对食管鳞状细胞癌(esophageal squamous cell carcinoma, ESCC)细胞体外功能的影响及其作用机制。利用TIMER2.0数据库、免疫组化及实时定量PCR(real-time quantitative PCR, RT-qPCR)分析IGF2BP1在ESCC组织和癌旁组织中的蛋白及mRNA水平。采用siRNA敲低IGF2BP1在KYSE30和TE-1细胞中的表达,利用CCK-8实验、平板集落形成实验、划痕愈合实验、 Transwell实验以及流式细胞术检测敲低IGF2BP1对细胞功能的影响。利用Western blot检测敲低IGF2BP1对上皮间质转化(epithelial-mesenchymal transition, EMT)相关蛋白及PI3K/AKT通路磷酸化水平的影响。利用STRING、 GEPIA数据库筛选出与IGF2BPl蛋白互作的其余N6-甲基腺嘌呤(N6-methyladenosine, m6A)甲基化酶并进行差异表达分析。通过RM2Target、 SRAMP数据库预测下游靶基因及其m6A修饰位点。结果显示,IGF2BP1在ESCC组织和细胞中高表达(P<0.05或P<0.001);敲低IGF2BP1后KYSE30和TE-1细胞增殖、迁移和侵袭能力减弱(P<0.05或P<0.001),细胞凋亡增多(P<0.05或P<0.001),同时促进E-cadherin的表达(P<0.05或P<0.01),抑制N-cadherin、 Vimentin的表达(P<0.05或P<0.01)以及PI3K/AKT通路的磷酸化(P<0.05或P<0.01);锌指CCCH结构域蛋白13(zinc finger CCCH domain containing protein 13, ZC3H13)与IGF2BP1蛋白互作且在ESCC中的表达水平与IGF2BP1正相关;ZC3H13和IGF2BP1共同调控的潜在靶基因CNNM2、KIAA1549、SP3均具有高可信度的m6A修饰位点。本研究提示,IGF2BP1可能通过m6A依赖的方式与其余m6A甲基化酶协调作用,激活PI3K/AKT通路的磷酸化而促进ESCC细胞的增殖、迁移、侵袭,抑制细胞凋亡,并促进EMT进程,发挥致癌作用。

     

    Abstract: The objective of this study was to investigate the impact and underly mechanism of insulin-like growth factor 2 mRNA binding protein 1(IGF2BP1) on the in vitro functions of esophageal squamous cells(ESCC). We employed the TIMER2.0 database, immunohistochemistry, and real-time quantitative PCR(RT-qPCR) to examine the protein and mRNA levels of IGF2BP1 in esophageal cancer tissues and adjacent tissues. The expression of IGF2BP1 in KYSE30 and TE-1 cells was suppressed using siRNA, the impact of IGF2BP1 knockdown on cell function was assessed through CCK-8 assay, colony formation assay, scratch wound hea-ling assay, Trans-well assay, and flow cytometry. Western blot analysis was conducted to evaluate the influence of IGF2BP1 knockdown on epithelial-mesenchymal transition(EMT)-related proteins and phosphorylation levels of the PI3K/AKT pathway. The remaining N~6-methyladenosine(m~6A) methylases interacting with IGF2BPl proteins were selected using the STRING, GEPIA databases and used for differential expression analysis.The downstream target genes and their m~6A modification sites were predicted by the RM2Target and SRAMP databases.The findings revealed that IGF2BP1 was highly expressed in both ESCC tissues and cells(P<0.05 or P<0.001). After knocking down IGF2BP1, the proliferation, migration, and invasion capacities of KYSE30 and TE-1 cells were significantly attenuated(P<0.05 or P<0.001), while cellular apoptosis was markedly increased(P<0.05 or P<0.001). Concurrently, it facilitated the upregulation of E-cadherin expression(P<0.05 or P<0.01) and suppressed the expression of N-cadherin and Vimentin(P<0.05 or P<0.01), as well as phosphorylation of the PI3K/AKT signaling pathway(P<0.05 or P<0.01).Zinc finger CCCH domain containing protein 13(ZC3H13) interacted with the IGF2BP1 protein, and its expression level exhibited a positive correlation with that of IGF2BP1 in ESCC.The potential target genes CNNM2, KIAA1549, and SP3, which were co-regulated by ZC3H13 and IGF2BP1, all possessed highly credible m~6A modification sites. This study suggested that IGF2BP1 may interacted with other m~6A methyltransferases in an m~6A-dependent manner to activate the phosphorylation of the PI3K/AKT pathway, thereby facilitated proliferation, migration, and invasion of ESCC cells. Additionally, it suppressed apoptosis and promoted EMT, thus exerted carcinogenic effects.

     

/

返回文章
返回